Immunotherapy Update: What We’ve Learned
Immunotherapy has been called one of the most significant advances in cancer in decades. While this approach may work in some cancers, it is unclear if or how immunotherapy can…
The Neuroendocrine Tumor Research Foundation directs your individual donations to breakthrough scientific research. Since 2005, we have funded $36 million in research projects. The Neuroendocrine Research Foundation is a 501(c)(3) organization, so all donations are fully tax-deductible to the extent allowed by law. We are grateful to you for your generosity.
The Neuroendocrine Tumor Research Foundation directs your individual donations to breakthrough scientific research. Since 2005, we have funded $36 million in research projects. The Neuroendocrine Research Foundation is a 501(c)(3) organization, so all donations are fully tax-deductible to the extent allowed by law. We are grateful to you for your generosity.
Immunotherapy has been called one of the most significant advances in cancer in decades. While this approach may work in some cancers, it is unclear if or how immunotherapy can…
Immunotherapy has been called one of the most significant advances in cancer in decades. While this approach may work in some cancers, it is unclear if or how immunotherapy can…
…will explore critical questions on the use of immunotherapy in NETs. What type of immunotherapy may be best suited for NETs? Tim Meyer, MD, PhD, UCL Cancer Institute, University College,…
…was integrally involved with the approval of CAR T-cell therapy, a personalized, breakthrough immunotherapy for blood cancer. The multipronged approaches will significantly increase the opportunity to develop efficacious NET-specific immunotherapy….
…system to launch one million minuscule heat-seeking missiles, whose sole purpose is to find and kill cancer cells. This is the basic premise behind an emerging form of immunotherapy, called…
Description Dr. McHugh and his research team are developing a personalized immunotherapeutic platform to treat atypical pulmonary carcinoids. What critical NET problem/question will researchers try to answer? The research team…
…HYDROCHLORIDE STREPTOZOCIN TEMOZOLOMIDE Immunotherapy Immunotherapy is a type of cancer treatment that helps the body’s immune system fight cancer. NETRF is funding studies to learn more about the role immunotherapy…
Description Cives and his team will work to develop a new form of immunotherapy for patients who have pancreatic NETs. Their approach aims to combine next-generation genetic sequencing technologies and…